| 2025-12-19 |
股东大会：
将于2026-01-30召开股东大会
会议内容 ▼▲
- 1.To elect six directors, each to hold office until the 2027 Annual Meeting of Stockholders and until his or her successor is elected and qualified;
2.To ratify the appointment of WithumSmith+Brown, PC as our independent registered public accounting firm for our fiscal year ending March 31, 2026;
3.To approve the Eighth Amended and Restated 2013 Equity Incentive Plan to increase the number of shares reserved for issuance by 850,000;
4.To approve, if necessary, the adjournment or postponement of the Annual Meeting, to continue to solicit votes if quorum is not met, or additional votes are required for any proposals;
5.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
6.Hiring the independent registered public accounting firm to conduct the annual audit of our consolidated financial statements and monitoring its independence and performance;
7.Reviewing and approving the planned scope of the annual audit and the results of the annual audit;
8.Pre-approving all audit services and permissible non-audit services provided by our independent registered public accounting firm;
9.Reviewing the significant accounting and reporting principles to understand their impact on our consolidated financial statements;
10.Reviewing our internal financial, operating and accounting controls with management, our independent registered public accounting firm and our internal audit provider;
11.Reviewing with management and our independent registered public accounting firm, as appropriate, our financial reports, earnings announcements and our compliance with legal and regulatory requirements;
12.Periodically reviewing and discussing with management the effectiveness and adequacy of our system of internal controls;
13.In consultation with management and the independent auditors, reviewing the integrity of our financial reporting process and adequacy of disclosure controls;
14.Reviewing potential conflicts of interest under and violations of our code of conduct;
15.Establishing procedures for the treatment of complaints received by us regarding accounting, internal accounting controls or auditing matters and confidential submissions by our employees of concerns regarding questionable accounting or auditing matters;
16.Reviewing and approving related-party transactions;
17.Reviewing and evaluating, at least annually, our audit committee’s charter.
|
| 2025-11-10 |
详情>>
股本变动：
变动后总股本800.95万股
变动原因 ▼▲
- 原因：
- From June 30,2025 to September 30,2025
Issuance of common stock – At The Market equity offering
Issuance of common stock upon exercise of warrants
|
| 2025-11-10 |
详情>>
业绩披露：
2026年中报每股收益-2.75美元,归母净利润-1563.1万美元,同比去年增长38.84%
|
| 2025-11-10 |
财报披露：
美东时间 2025-11-10 盘后发布财报
|
| 2025-08-12 |
详情>>
业绩披露：
2026年一季报每股收益-1.53美元,归母净利润-769.1万美元,同比去年增长36.96%
|
| 2025-07-21 |
详情>>
内部人交易：
Lisi Steven A.股份增加6000.00股
|
| 2025-07-12 |
复牌提示：
2025-07-11 19:50:00 停牌，复牌日期 2025-07-14 09:00:00
|
| 2025-07-12 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2025-06-20 |
详情>>
业绩披露：
2025年年报每股收益-0.69美元,归母净利润-4662.5万美元,同比去年增长22.60%
|
| 2025-05-05 |
股东大会：
将于2025-06-20召开股东大会
会议内容 ▼▲
- 1.To approve the third amendment to our Amended and Restated Certificate of Incorporation, as amended, in the form attached to the proxy statement as Annex A, to, at the discretion of our Board of Directors (the “Board”), effect a reverse stock split of our issued and outstanding shares of common stock, par value $0.0001 per share (the “Common Stock”), at any time prior to the one-year anniversary date of the Special Meeting, at a ratio, ranging from one-for-ten (1:10) to one-for-fifty (1:50), with the exact ratio to be set within that range at the discretion of the Board without further approval or authorization of our stockholders (the “Reverse Stock Split Proposal” or “Proposal 1”);
2.To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Reverse Stock Split Proposal (the “Adjournment Proposal” or “Proposal 2”).
|
| 2025-02-10 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.64美元,归母净利润-3859.1万美元,同比去年增长17.07%
|
| 2024-11-12 |
详情>>
业绩披露：
2025年中报每股收益-0.55美元,归母净利润-2555.9万美元,同比去年增长15.69%
|
| 2024-10-31 |
股东大会：
将于2024-11-22召开股东大会
会议内容 ▼▲
- 1.To elect six directors, each to hold office until the 2026 Annual Meeting of Stockholders and until his or her successor is elected and qualified;
2.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2025;
3.To approve the Seventh Amended and Restated 2013 Equity Incentive Plan to increase the number of shares reserved for issuance by 3,000,000 and to give the Board authority, without stockholder approval, to (i) modify the exercise or grant price of an option or stock appreciation right after it is granted, (ii) cancel an option or stock appreciation right at a time when its exercise or grant price exceeds the Fair Market Value of the underlying stock, in exchange for cash, another option or stock appreciation right, restricted stock, or other equity award, or (iii) take any other action that is treated as a repricing under generally accepted accounting principles;
4.To approve, by an advisory (non-binding) vote, named executive officer compensation;
5.To approve the second amendment to our Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 100,000,000 to 500,000,000;
6.To authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock underlying warrants issued by us pursuant to the terms of that certain Securities Purchase Agreement, dated September 26, 2024, by and among Beyond Air, Inc. and the investors named therein, in an amount equal to or in excess of 20% of our common stock outstanding before the issuance of such warrants (including in accordance with the operation of anti-dilution provisions contained in such warrants);
7.To approve, if necessary, the adjournment or postponement of the Annual Meeting, to continue to solicit votes for Proposals 3, 5 and 6;
8.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2024-08-06 |
详情>>
业绩披露：
2025年一季报每股收益-0.27美元,归母净利润-1220.1万美元,同比去年增长13.44%
|
| 2024-06-24 |
详情>>
业绩披露：
2024年年报每股收益-1.82美元,归母净利润-6024.2万美元,同比去年增长-7.93%
|
| 2024-02-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.46美元,归母净利润-4653.5万美元,同比去年增长-30.54%
|
| 2024-01-26 |
股东大会：
将于2024-03-08召开股东大会
会议内容 ▼▲
- 1.To elect seven directors, each to hold office until the 2025 Annual Meeting of Stockholders and until his or her successor is elected and qualified;
2.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2024;
3.To approve the Sixth Amended and Restated 2013 Equity Incentive Plan to increase the number of shares reserved for issuance by 3,000,000;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2023-11-13 |
详情>>
业绩披露：
2024年中报每股收益-0.96美元,归母净利润-3031.5万美元,同比去年增长-32.37%
|
| 2023-08-10 |
详情>>
业绩披露：
2024年一季报每股收益-0.45美元,归母净利润-1409.5万美元,同比去年增长-28.91%
|
| 2023-01-27 |
股东大会：
将于2023-03-09召开股东大会
会议内容 ▼▲
- 1.To elect seven directors, each to hold office until the 2024 Annual Meeting of Stockholders and until his or her successor is elected and qualified;
2.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2023;
3.To approve the Fifth Amended and Restated 2013 Equity Incentive Plan to increase the number of shares reserved for issuance by 3,000,000;
4.To approve, by an advisory (non-binding) vote, the frequency of future advisory votes on the compensation of our named executive officers;
5.To approve, by an advisory (non-binding) vote, named executive officer compensation;
6.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2022-01-21 |
股东大会：
将于2022-03-03召开股东大会
会议内容 ▼▲
- 1.To elect seven directors, each to hold office until the 2023 Annual Meeting of Stockholders and until his or her successor is elected and qualified;
2.To ratify the appointment of Friedman LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2022;
3.To approve the Fourth Amended and Restated 2013 Equity Incentive Plan to increase the number of shares reserved for issuance by 2,000,000;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-01-22 |
股东大会：
将于2021-03-04召开股东大会
会议内容 ▼▲
- 1.To elect seven directors, each to hold office until the 2022 Annual Meeting of Stockholders and until his or her successor is elected and qualified;
2.To ratify the appointment of Friedman LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2021;
3.To approve the Third Amended and Restated 2013 Equity Incentive Plan to increase the number of shares reserved for issuance by 1,500,000;
4.To approve the Beyond Air, Inc. 2021 Employee Stock Purchase Plan;
5.To amend our Amended and Restated Certificate of Incorporation, as amended, to add a federal forum selection provision;
6.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-01-17 |
股东大会：
将于2020-03-04召开股东大会
会议内容 ▼▲
- 1. To elect seven directors, each to hold office until the 2021 Annual Meeting of Stockholders and until his or her successor is elected and qualified;
2. To ratify the appointment of Friedman LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2020;
3. To approve the Second Amended and Restated 2013 Equity Incentive Plan to increase the number of shares reserved for issuance by 1,000,000;
4. To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|